A B S T R A C T The close anatomical relationships between pancreatic alpha and beta cells makes possible their interaction at a local (paracrine) level. To demonstrate this in vivo, we have compared the acute glucagon response to intravenous arginine in the basal state and after beta cell suppression by infusions of insulin. The plasma glucose concentration was maintained by the glucose clamp technique. In six normal weight nondiabetics, infusion of insulin at 0.2 mU/kg per min (rate 1) raised the mean±SEM plasma insulin levels from 10±3 to 32±4 mU/liter and at 1 mU/kg per min (rate 2) raised plasma insulin to 84±8 mU/liter. This resulted in beta cell suppression, as shown by a diminution in the acute insulin response (incremental area under the insulin response curve, 0-10 min): basal = 283+61, 199±66 (rate 1) and 143±48 mU/liter per 10 min (rate 2) and a fall in prestimulus C-peptide from 1.05±0.17 to 0.66±0.15 and to 0.44±0.15 nM/liter (all P < 0.01). This beta cell suppression was associated with increased glucagon responses to arginine: 573±75 (basal), 829±114 (rate 1), and 994±136 ng/liter per 10 min (rate 2) and increased peak glucagon responses 181±11 (basal), 214±16 (rate 1), and 259±29 ng/liter (rate 2) (all P < 0.01). In all subjects, there was a proportional change between the rise in the acute glucagon response to arginine and the fall in the prearginine C-peptide level. To demonstrate that augmented glucagon response was due to beta cell suppression, and not to the metabolic effect of infused insulin, similar studies were performed in C-peptide-negative-diabetics. Their acute glucagon response to arginine was
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INTRODUCTION
The regulation of pancreatic alpha cell secretion is probably mediated by complex interactions between multiple factors that include neural influences, circulating fuels, and gastrointestinal hormones. In addition, the close anatomical relationship between hormonally active cells in the islet of Langerhans makes it very likely that alpha cell secretion is influenced by the local concentration of other islet hormones (1) . Such a local action has been termed "paracrine" in contrast to the endocrine action of pancreatic hormones, which is mediated through general circulation. The ability of insulin to inhibit glucagon secretion has previously been demonstrated in vitro in isolated islets, pancreatic pieces (2), or whole pancreas (3) (4) (5) . The administration of exogenous insulin in vivo causes many changes in circulating fuels (especially glucose) and hormones, in particular the suppression of endogenous insulin secretion (6) (7) (8) . Any effect this fall in endogenous paracrine insulin secretion may have on glucagon secretion cannot be discerned because of simultaneous changes in circulating fuels and hormones that also affect glucagon release. The glucose clamp technique (9) enables the circulating level of insulin to be raised without changing plasma glucose concentration. Endogenous insulin secretion, as measured by C-peptide determinations, is inhibited (6) (7) (8) and thereby provides a model to investigate the paracrine effect of insulin on A cell secretion independent of any change in plasma glucose. We have, therefore, measured the acute glucagon responses to intravenous arginine in normal men, before and after insulin infusions, using the glucose clamp technique. RESULTS Blood glucose levels were maintained constant at basal values (Table I) in all subjects during the insulini in-fusion (CV < 3%). Suppression of endogenous insulin secretion in the nondiabetic subjects was documented by the progressive fall in prestimulus C-peptide levels from a mean basal level of 1.05+±0.17 nmol/ liter to 0.66+0.15 at insuilini rate I, and to 0.44+0.15 at insulin rate II. In addition, the AIR to arginine fell in all subjects, being 283±+61 mU/liter per 10 min in the basal state, and 199+66 and 143+48 mU/liter per 10 min at insulin rates I and II, respectively (P < 0.01 for all comparisons) ( Table I and Fig. 1) .
In all the nondiabetic subjects, the AGR to arginine was greater at insulin infusion rate 1 Table I and Fig. 1 ). In all subjects there was a strong relationship between prestimulus Cpeptide levels and the AGR although the slope of these lines was variable (Fig. 2) . The peak IRG response postarginine, irrespective of time, also increased progressively: basal = 181+11, rate I = 214+16, rate II = 259+29 ng/liter (P< 0.01) ( Table I) .
None of the diabetics had detectable circulating C-peptide levels. Their basal AGR was 701+112 ng/ liter per 10 min and the AGR fell to 427+33 ng/liter per 10 min when insulin was infused at rate I and fell further to 293+±67 ng/liter per 10 min at insulin rate II (P < 0.01). Similarly, the peak IRG level postarginine, irrespective of time, also decreased in every diabetic during the infusion of insulin ( Fig. 1 and Table I ). Three of the diabetics studied were normoglycemic C-peptide levels (nmol/liter). 1, liter. at the time of the studv. We have also studied six additional diabetics (two of whom were also normoglycemic) in the basal state and after instulin infutsioni (rate II). The basal AGR (596+41 ng/liter per 10 min) and the AGR at insuilin infusion rate 11 (328±70 Imig/ liter per 10 min) in these five normoglveemic (meani plasma glucose = 82+ 10 mg/dl) diabetics were similar to the responses seen in the diabetics as a group. Also, there was no correlation between the AGR in the basal state and the fall in the AGR as a result of the insulin infusion and the plasma glucose level.
The prestimulus IRG levels fell in both nondiabetics and diabetics from basal valuies of 78+15 ng/liter and 114+33 ng/liter, respectively, to 56±10 ng/liter and 87±35 ng/liter during insulin infuision rate 1, and to 64±10 ng/liter and 82± 11 ng/liter during insulin infusion rate I1. No consistent change in serum potassium was noted, the greatest change being 0.2 mmol/liter.
DISCUSSION
This study has demonstrated enhancemenit of the alpha cell response to arginine during suippressioni of beta cell secretion in nondiabeties. This suggests that the beta cell, fuinctioninig in a paracrine fashion, inhibits alpha cell secretion in vivo, similar to the inhibition of glucagon secretion by insulin in vitro (2) (3) (4) (5) . This has not been previously dcemonstrated in miian.
Suppression of enidogenouis inisuilin in the noindiabeties is shown by the progressive fall in prestimiiulus C-peptide levels anid by the fall in AIR to arginine in all subjects. Thus, wlhen the plasma glucose level remc-ains constant, endogenous insulin secretioni can be stuppressed by insulini infusion rates that give circulating instulini levels within the physiological range. In previous stucdies, supraphysiological (7) and phvsiological (6) serumil insulin levels have been uised to suippress endogeniouis insulini secretioni (as shown by C-peptide levels). In the isolated pancreas, insulill itself (8) will suppress beta cell instulini secretioni, however, in this study, it is not known whether the exogenous insulin suppressed beta cell function directlv, or via a chanlge in one of maniy circulatinig fuels (other than glucose), hormones, or by a combination thereof. In nondiabetics, the overall effect on the pancreatic alpha cell was a progressively greater AGR to arginine during the insulin infusions, probably due to a lesser A cell suppression by paracrine beta cell activity. In diabetics, who lack any detectable beta cell secretory capacity, this response was not observed; in fact, the opposite, inhibition of the AGR to arginine, was found.
The changes in AGR are not merely seconidary to chainges in prestimulus IRG levels because peak IRG after the arginine pulse, irrespective of time, rose progressively in all nionidiabetics and fell progressively in alll diabetics. The inciremiienital area is calcuilated from the lowered basal level. However, the alpha cells could ha,ve been affected by changes in circulatinig free fatty acids, ketonie bodies, or amino acids brought about by! the insulini infusions. Sinice the circulalting fuels in diabetics anid nondiabetics wouild be expected to show similar qualitative chaniges during the instulini infusionis, whereas the glucagoni responses we observed were in opposite directions, it is unlikely that the rises in AGR in nondiabeties during the insuilini infusion are a result of somne chainge in levels of circulating fuels. The similarity of AGR seen when normoglycemic and hvperglycem ic diabetics were compared miakes it unlikely that the differences observed between diabetics and noncdiabetics are secondary to differenees in circullating fuels. This is further suipported by the absence of any relationship between the plasmiia glucose level and basal AGR or the degree of fall in the AGR brought about by instulin infusion. It is more likely that the differenice between nonidiabetics and dial)etics is duie primarily to differeniees in beta cell paracrinie inhibition of alpha cells.
The prestimultllus IRG levels fell in both diabetics aind nondial)etics. This is presumilably partly in response to chaniges in cireculating ftuels other thain gltucose brought about by the instulini infusioni, buit is comiiplicated by the lacek of knowledge of the source of IRG mleasured in the basal state. In contrast, the IRG seen after argininie injectioin appears to be 3,500 dalton gluteagon of pancreatic origin. In support of this possibility is the observation that in pancreatectoimlized Paracritne Inhibitiont of Glucagon 317 'I-, man l)asal IRG is often normlal but the responise to argininie is minimial (15) . It is possible that basal glucagoni is largely nonpancreatic in origin, therefore not undcler paracrinie insulini influenice, and is inhibited by exogenious insulini (16) similar to pancreatic alpha cells in insulini-depenidenit dialetics who lack paracrine beta cells. Thus, studies in which insulin, with or without glucose, hals been infused into dialetics and(I nonodiabetics followed by chaniges in basal IRG, are not comparable with the argininie stimiiulated IRG data in the present study (5, 17, 18) .
The importanice of paracrine insulini in inhibiting alpha cell secretion might provide anl explanation for the observations that during insulin induced hypoglycemila, insulin dependent diabetics have a markedly deficienit or absent IRG response compared to n1on1-diabetics (19, 20) . The IRG response to hypoglycemia would be comparable to the stimulated (by arginine) IRG response presenited here. Hypoglycemia would suppress paracrine insulin in nondiabetics resulting in decreased inhibition of the alpha cell. If this was an important factor in IRG response to hypoglycemia, insulini dependent diabetics who lack such a mechanismii would be expected to have anl impaired IRG responise. Also, the inconsistenit IRG responses of insulini depenidenit diabetics (without hypoglycemia) to insulin may l)e related to the varyinig degrees of l)eta cell destructioni in these dial)etics (21) .
Previous morphologic and in vitro observations have suggested that beta cells affect alpha cell secretion by a paracrine mechaniismii (1) (2) (3) (4) (5) . Our data extend these observations to m11an1 anid suggest that the distuirbed paracrine relationship of alpha and beta cells in diabetes maiy explain, in part, the abnormal gluicagon dynamics ob)served in diabetes.
